MGMT and glioblastoma: Here, based on the DNA methylation status of the O6-methylguanine-DNA methyltransferase (MGMT) gene promoter region, the clinical response of glioblastomas to temozolomid chemotherapy clearly differs and, therefore, affects the choice of chemotherapy [37].